AAAAAA

   
Results: 1-25 | 26-29 |
Results: 26-29/29

Authors: LOCKER GJ SIMONITSCH I MADER RM WARLAMIDES E GNANT MFX JAKESZ R RAINER H STEGER GG
Citation: Gj. Locker et al., CUTANEOUS SIDE-EFFECTS IN BREAST-CANCER PATIENTS TREATED WITH CYTOSTATIC POLYCHEMOTHERAPY AND RH GM-CSF - IMMUNE PHENOMENA OR DRUG TOXICITY, Breast cancer research and treatment, 34(3), 1995, pp. 213-219

Authors: LACZIKA K STAUDINGER T LOCKER GJ KNAPP S BURGMANN H FRASS M
Citation: K. Laczika et al., TETRIS AND PHYSICIANS PERFORMANCE STATE, Lancet, 346(8973), 1995, pp. 516-516

Authors: LOCKER GJ MADER RM BRAUN J SIEDER AE MAROSI C RAINER H JAKESZ R STEGER GG
Citation: Gj. Locker et al., NEW MUCIN-LIKE CANCER-ASSOCIATED ANTIGENS (CA-M-26, CA-M-29 AND CA-549) AND A NEW PROLIFERATION MARKER (TPS) IN PATIENTS WITH PRIMARY OR ADVANCED BREAST-CANCER, Oncology, 52(2), 1995, pp. 140-144

Authors: WAGNER A MAROSI C BINDER M ROGGLA G STAUDINGER T KEIL F LOCKER GJ FRASS M
Citation: A. Wagner et al., FATAL POISONING DUE TO DAPSONE IN A PATIENT WITH GROSSLY ELEVATED METHEMOGLOBIN LEVELS, British journal of dermatology, 133(5), 1995, pp. 816-817
Risultati: 1-25 | 26-29 |